/PRNewswire/ Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for.
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th.